RT @CNN: The US fertility rate has dropped to the lowest number reported since record-keeping about it began t.co/oQGtECRKcz
RT @RESOLVENewEng: Shout out to #NEWoH2017 Presenting Sponsor @OvaScience ! See you 9/17 at @EndicottEstate1 ! sign up here: t.co/k…
Be sure to see @Hudson_Research news release on "The molecular characterization of porcine egg precursor cells." t.co/ZCRBINiUGL
Shout out 2 $OVAS Dr. Yvonne White, co-author of "The molecular characterization of porcine egg precursor cells." t.co/7x6oM0A8Ny
OvaScience makes miracles happen. Founded in 2011, with the goal of improving the treatment of infertility, the company assembled a team of scientists, physicians and advisers that are recognized leaders in the field of reproductive medicine. In 2015, baby Zain Rajani was born. Zain was the first baby born with the assistance of OvaScience's first product (AUGMENT) which increases the success of in vitro fertilization (IVF) and uses the mothers own cellular energy to revitalize her egg. For Bessemer, backing the OvaScience founders in 2011 was an easy decision. We’d funded Michelle Dipp, Christoph Westphal, and Rich Aldrich before. (In fact, we’ve funded Christoph five times!) OvaScience (NASDAQ: OVAS) became a public company in 2012.